Microtubules in vascular endothelial barrier regulation | 51986
Clinical & Experimental Cardiology

Clinical & Experimental Cardiology
Open Access

ISSN: 2155-9880

+44 1300 500008

Microtubules in vascular endothelial barrier regulation

5th International Conference on Clinical & Experimental Cardiology

April 27-29, 2015 Philadelphia, USA

Alexander D Verin

Scientific Tracks Abstracts: J Clin Exp Cardiolog

Abstract :

The vascular endothelium (EC) acts as a semi-selective barrier between the interior space of blood vessels and underlying tissues. Disruption of the EC barrier is a prominent feature of acute lung injury (ALI). EC permeability is regulated by a balance between contractile and tethering forces and is dependent on the functional coordination of interrelated elements of the cytoskeleton, namely microfilaments (MF) and microtubules (MT). Edemagenic agents such as the serine protease thrombin induce EC barrier dysfunction primarily via MF-driven contraction. In contrast, information about the role of the MT network in EC barrier regulation is limited. Our data indicate that MT remodeling is directly involved in thrombin-induced EC barrier compromise. MT disruption by microtubule inhibitors or thrombin, significantly increases EC permeability. Conversely, stabilization of MTs by taxol protects EC barrier in vitro and in murine model of ALI indicating the importance of MTs in maintaining the EC barrier. Thrombin-induced EC barrier compromise involves activation of heterotrimeric G-proteins, G12 and G13, followed by activation of Rho and p38 MAPK signaling. Inhibition of this cascade attenuates the effect of thrombin on MT structure suggesting the involvement of these pathways in MT remodeling. Thrombin induces phosphorylation of several MT- and MF-associated regulatory proteins, including caldesmon, HSP-27 and tau, which are potentially responsible for thrombin-induced changes in MF and MF structure. We hypothesize that thrombin-induced activation of G12 and G13 leads to activation of Rho and p38 MAPK signaling, phosphorylation of cytoskeletal regulatory proteins, coordinated MT and MF remodeling and finally to barrier compromise.

Biography :

Alexander D Verin has completed his PhD at the age of 29 years from Moscow State University, Moscow, Russia and Postdoctoral studies from Indiana University, Indianapolis, IN. He is the Professor of Vascular Biology and Medicine at Vascular Biology Center and Division of Pulmonary Medicine, School of Medicine, Georgia Regents University, Augusta, GA. He has published more than 135 papers in reputed journals and has been serving as an editorial board member of reputable American Journal of Physiology (Lung) and many others.